Sickle Cell Disease Clinical Trials
Sickle Cell Disease clinical trials are research studies evaluating new treatments, therapies, and approaches for sickle Cell Disease. Corterve aggregates actively recruiting Sickle Cell Disease studies from the public ClinicalTrials.gov registry so you can browse them by location and eligibility criteria. Participation is always voluntary. This page provides general information and is not medical advice; discuss any trial with your healthcare provider before taking part.
Recruiting Sickle Cell Disease studies
- Collection of Human Biospecimens for Basic and Clinical Research Into Globin VariantsNCT03937817National Institute of Allergy and Infectious Diseases (NIAID)Bethesda, Maryland
- Partial Stem Cell Transplant for Sickle Cell Disease From Matched DonorsNCT07599176PHASE1, PHASE2National Heart, Lung, and Blood Institute (NHLBI)Bethesda, Maryland
- A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)NCT07187973PHASE1Disc Medicine, IncBirmingham, Alabama
- The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell DiseaseNCT06975865PHASE3SanofiBirmingham, Alabama
- Blood Sampling for Research Related to Sickle Cell DiseaseNCT00542230National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Bethesda, Maryland
- Escalating Doses of VAS-101 in Subjects With Stable Sickle Cell DiseaseNCT07566494PHASE1National Heart, Lung, and Blood Institute (NHLBI)Bethesda, Maryland
- Arginine Therapy for the Treatment of Pain in Children With Sickle Cell DiseaseNCT02447874PHASE1, PHASE2Emory UniversityAtlanta, Georgia
- Myeloablative Conditioning, Prophylactic Defibrotide and Haplo AlloSCT for Patients With Sickle Cell DiseaseNCT02675959PHASE2New York Medical CollegeLos Angeles, California
- Cooperative Assessment of Late Effects for SCD Curative TherapiesNCT05153967Vanderbilt University Medical CenterWashington D.C., District of Columbia
- A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)NCT06439082PHASE3Novartis PharmaceuticalsBirmingham, Alabama
- Haploidentical Donor Hematopoietic Cell Transplant for Sickle Cell DiseaseNCT07616154PHASE2St. Jude Children's Research HospitalMemphis, Tennessee
- A Pilot Study on Neuroimaging in SCD: Part of The Boston Consortium to Cure Sickle Cell DiseaseNCT04166526Boston Children's HospitalBoston, Massachusetts
Sickle Cell Disease trials by state
Sickle Cell Disease trials by metro
Frequently asked questions
- How do I find recruiting Sickle Cell Disease clinical trials?
- Corterve aggregates actively recruiting Sickle Cell Disease studies from the public ClinicalTrials.gov registry. Browse the studies listed on this page or take a free health assessment to see trials you may qualify for based on your profile.
- Are Sickle Cell Disease clinical trials free to join?
- Study participation is typically free — research sponsors cover the cost of the investigational treatment and study-related visits. Many trials also compensate participants for time and travel. Details vary by study.
- Who can take part in a Sickle Cell Disease clinical trial?
- Each study has its own eligibility criteria (for example age, disease stage, and prior treatments). This page is general information and not medical advice; discuss any specific trial with your healthcare provider to confirm whether it is appropriate for you.